Menu
Shang Li Picture Min

Innovative Facial Regeneration

By Dr Shang-Li Lin

Find an expert
Model is not an actual patient.

I see a lot of innovation in the field of aesthetic medicine and make sure I keep abreast of the latest developments so
that I can maintain the highest possible standard of practice.

Innovative Facial Regeneration

It’s hugely important to be able to offer my patients the very best treatment and experience. Five years ago, when researching injectables, I came across ELLANSÉ, a Polycaprolactone (PCL)-based collagen stimulator that enables immediate correction of facial ageing and imperfections. I knew instantly that this was the cutting-edge product I had been looking for.

View patient testimonials
Actual patient. Individual results may vary
Squre 04

Innovative Facial Regeneration

One Solution

Using a collagen stimulator which allows a high degree of refinement allows us to address various signs of facial ageing, such as brow ptosis, the appearance of jowls, and loss of facial definition to name a few. Using ELLANSÉ exclusively, I can get results that are much more effective and precise than those achieved through other injectables.
01 Copy
Model is not an actual patient.
Learn more about EllansÉ
This is a great opportunity for physicians - a versatile product with a great potential and a strong safety profile - Dr Shang-LI Lin

How important a breakthrough is ELLANSÉ?

Francisco Min

Restoring youth and enhancing form

By Dr Francisco De Melo
Shang Li Min

Innovative Facial Regeneration

By Dr Shang-Li Lin
Amanda Min

Restoring volume and contours through collagen stimulation

by Dr Amanda Ong
View patient testimonials
Clinic Finder Banner

Find your clinic

Search your location or postcode to find a physician near you

FIND A CLINIC

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

 

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising.

 

Other potential adverse events include

- Injection related reactions, include itching, discoloration or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.

- As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, haematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, oedema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at implant site which may result in induration and/or scar formation.

- Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia and neurological complications.

- Adverse events, other than mentioned above, could occur as can be with any medical intervention.

All (potential) adverse side effects and incidents should be reported immediately to the Sinclair Corporate Safety Group: quality@sinclair.com

For a full list of contraindications, warnings, and precautions for this product please visit here for a copy of the Product Instructions for Use.